{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:01:00Z","timestamp":1790020860481,"version":"4.0.1"},"reference-count":45,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"Sinopharm Healthcare"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Policy and Practice"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/20523211.2026.2701914","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:03:21Z","timestamp":1790017401000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Integrated AHP-Delphi and Mini-HTA for selection of metabolic drugs in China\u2019s national medical insurance catalog: a framework towards quantitative dynamic adjustment"],"prefix":"10.1080","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9469-7787","authenticated-orcid":false,"given":"Jiajin","family":"Li","sequence":"first","affiliation":[{"name":"Peking University","place":["Beijing, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2061-1507","authenticated-orcid":false,"given":"Tianxiao","family":"Huang","sequence":"additional","affiliation":[{"name":"Xi'an Jiaotong University","place":["Xi'an, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9489-4820","authenticated-orcid":false,"given":"Yujie","family":"Sun","sequence":"additional","affiliation":[{"name":"Peking University","place":["Beijing, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3543-4035","authenticated-orcid":false,"given":"Lu","family":"Yu","sequence":"additional","affiliation":[{"name":"Peking University","place":["Beijing, People\u2019s Republic of China"]},{"name":"Sinopharm Group","place":["Beijing, People\u2019s Republic of China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"e_1_3_8_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/jech.2007.059576"},{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-5-37"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(23)00119-5"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.34172\/ijhpm.2020.244"},{"key":"e_1_3_8_6_1","unstructured":"Center for Drug Evaluation N. M. P. A. (2022). 2022 Annual drug review report [2022\u5e74\u5ea6\u836f\u54c1\u5ba1\u8bc4\u62a5\u544a]. https:\/\/www.cde.org.cn\/main\/news\/viewInfoCommon\/849b5a642142fc00738aff200077db11."},{"key":"e_1_3_8_7_1","unstructured":"Center for Drug Evaluation N. M. P. A. (2023). 2023 Annual drug review report [2023\u5e74\u5ea6\u836f\u54c1\u8bc4\u5ba1\u62a5\u544a]. https:\/\/www.cde.org.cn\/main\/news\/viewInfoCommon\/b2e1b6d57a6c45c4af1c6a7b9bebbc2a."},{"key":"e_1_3_8_8_1","unstructured":"Center for Drug Evaluation N. M. P. A. (2024). 2024 Annual drug review report [2024\u5e74\u5ea6\u836f\u54c1\u8bc4\u5ba1\u62a5\u544a]. \u56fd\u5bb6\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40. https:\/\/www.cde.org.cn\/main\/news\/viewInfoCommon\/54538c67b7e764fc51666567fc620241."},{"key":"e_1_3_8_9_1","unstructured":"China News Service. (2024 10 September 2024). National Healthcare Security Administration elaborates on the \u201c1+3+N\u201d multi-level medical security system[\u56fd\u5bb6\u533b\u4fdd\u5c40\u8be6\u89e3\u201d1+3+N\u201d\u591a\u5c42\u6b21\u533b\u7597\u4fdd\u969c\u4f53\u7cfb]. https:\/\/www.chinanews.com.cn\/gn\/2024\/09-10\/10283388.shtml."},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989(8900900108"},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-019-0977-z"},{"key":"e_1_3_8_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.8094"},{"key":"e_1_3_8_13_1","unstructured":"General Office of the State Council of the People's Republic of China. (2023). Implementation opinions on strengthening routine supervision of healthcare fund usage [\u56fd\u52a1\u9662\u529e\u516c\u5385\u5173\u4e8e\u52a0\u5f3a\u533b\u7597\u4fdd\u969c\u57fa\u91d1\u4f7f\u7528\u5e38\u6001\u5316\u76d1\u7ba1\u7684\u5b9e\u65bd\u610f\u89c1]. (Guobanfa [2023] No. 17). The Central People's Government of the People's Republic of China\u200b. Retrieved from https:\/\/www.gov.cn\/zhengce\/content\/202305\/content_6883811.htm."},{"key":"e_1_3_8_14_1","unstructured":"General Office of the State Council of the People's Republic of China. (2024). Opinions on comprehensively deepening the reform of drug and medical device regulation and promoting the high-quality development of the pharmaceutical industry [\u56fd\u52a1\u9662\u529e\u516c\u5385\u5173\u4e8e\u5168\u9762\u6df1\u5316\u836f\u54c1\u533b\u7597\u5668\u68b0\u76d1\u7ba1\u6539\u9769\u4fc3\u8fdb\u533b\u836f\u4ea7\u4e1a\u9ad8\u8d28\u91cf\u53d1\u5c55\u7684\u610f\u89c1]. (Guobanfa [2024] No. 53). Retrieved from https:\/\/www.gov.cn\/zhengce\/content\/202501\/content_6996115.htm."},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/1525822X05279903"},{"key":"e_1_3_8_16_1","volume-title":"IDF diabetes atlas","author":"International Diabetes Federation","year":"2025","unstructured":"International Diabetes Federation. (2025). IDF diabetes atlas (11th ed.). https:\/\/diabetesatlas.org\/resources\/idf-diabetes-atlas-2025\/"},{"issue":"1","key":"e_1_3_8_17_1","first-page":"100","article-title":"Development of HTA in the healthcare insurance systems of developed countries and its implications for China [HTA\u5728\u53d1\u8fbe\u56fd\u5bb6\u533b\u4fdd\u4f53\u7cfb\u4e2d\u7684\u53d1\u5c55\u53ca\u5bf9\u6211\u56fd\u7684\u542f\u793a]","author":"Jiajin L.","year":"2024","unstructured":"Jiajin, L., Tianxiao, H., Yujie, S., & Lu, Y. (2024). Development of HTA in the healthcare insurance systems of developed countries and its implications for China [HTA\u5728\u53d1\u8fbe\u56fd\u5bb6\u533b\u4fdd\u4f53\u7cfb\u4e2d\u7684\u53d1\u5c55\u53ca\u5bf9\u6211\u56fd\u7684\u542f\u793a]. China Healthcare Security. (1), 100\u2013110. https:\/\/cstj.cqvip.com\/Qikan\/Article\/Detail?id=7111353552 (in chinese)","journal-title":"China Healthcare Security"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1674-2982.2023.02.005"},{"issue":"4","key":"e_1_3_8_19_1","first-page":"59","article-title":"Enlightenment of WHO and some countries\u2019 selection and withdrawal standards of essential medicine to China [WHO\u548c\u90e8\u5206\u56fd\u5bb6\u57fa\u672c\u836f\u7269\u9074\u9009\u4e0e\u9000\u51fa\u6807\u51c6\u5bf9\u6211\u56fd\u7684\u542f\u793a]","volume":"15","author":"Jianzhou Y.","year":"2022","unstructured":"Jianzhou, Y., Ruilin, D., & Rong, S. (2022). Enlightenment of WHO and some countries\u2019 selection and withdrawal standards of essential medicine to China [WHO\u548c\u90e8\u5206\u56fd\u5bb6\u57fa\u672c\u836f\u7269\u9074\u9009\u4e0e\u9000\u51fa\u6807\u51c6\u5bf9\u6211\u56fd\u7684\u542f\u793a]. Chinese Journal of Health Policy, 15(4), 59\u201366. (in Chinese).","journal-title":"Chinese Journal of Health Policy"},{"key":"e_1_3_8_20_1","first-page":"37","article-title":"Safeguarding national data security with blockchain technology [\u4ee5\u533a\u5757\u94fe\u6280\u672f\u7ef4\u62a4\u56fd\u5bb6\u6570\u636e\u5b89\u5168]","volume":"08","author":"Jin D.","year":"2024","unstructured":"Jin, D. (2024). Safeguarding national data security with blockchain technology [\u4ee5\u533a\u5757\u94fe\u6280\u672f\u7ef4\u62a4\u56fd\u5bb6\u6570\u636e\u5b89\u5168]. China Cyberspace, 08, 37\u201340. https:\/\/kns.cnki.net\/kcms2\/article\/abstract?v=gHWJqxSIlt2q1brs1zXnEAgOgCVSY4VrHI0qgm0Sx-og_91lEyTMsmlYhsdqkHzMkvtS6_vu6EeV3E6FGlgtKHxN1a2UuB3EufPf4VTi7g-tWfrzE-gRTDgwMJzsigPwB2srml9jrrLq5snfr8N2mnmLtNvrS6WhUuVZPIGH3GafDC_ExYJGmMZiyzN7eyBjXVO0_EoMsMg=&uniplatform=NZKPT&language=CHS (in Chinese)","journal-title":"China Cyberspace"},{"key":"e_1_3_8_21_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.3c01619"},{"key":"e_1_3_8_22_1","unstructured":"Kenya National Bureau of Statistics. (2022). Kenya demographic and health survey 2022 (DDI-KEN-KNBS-KDHS-2022-V001). https:\/\/statistics.knbs.or.ke\/nada\/index.php\/catalog\/128."},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-023-01043-8"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejor.2007.05.001"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-019-6569-8"},{"key":"e_1_3_8_26_1","unstructured":"Ministry of Health and Family Welfare. (2022). National List of Essential Medicines (NLEM) 2022. G. o. India. https:\/\/mohfw.gov.in\/?q=newshighlights-104."},{"key":"e_1_3_8_27_1","unstructured":"National Healthcare Security Administration (NHSA). (2020). Interim measures for the administration of medicines covered by basic medical insurance [\u57fa\u672c\u533b\u7597\u4fdd\u9669\u7528\u836f\u7ba1\u7406\u6682\u884c\u529e\u6cd5]. Retrieved from https:\/\/www.nhsa.gov.cn\/attach\/0\/bab0c20ab5604f69ab84ae22ab520274.pdf."},{"key":"e_1_3_8_28_1","doi-asserted-by":"publisher","DOI":"10.13558\/j.cnki.issn1672-3686.2023.006.002"},{"issue":"6","key":"e_1_3_8_29_1","first-page":"521","article-title":"Report on the nutrition and chronic diseases status of Chinese residents 2020 [\u4e2d\u56fd\u5c45\u6c11\u8425\u517b\u4e0e\u6162\u6027\u75c5\u72b6\u51b5\u62a5\u544a(2020\u5e74)]","volume":"42","author":"National Health Commission of the PRC.","year":"2020","unstructured":"National Health Commission of the PRC. (2020). Report on the nutrition and chronic diseases status of Chinese residents 2020 [\u4e2d\u56fd\u5c45\u6c11\u8425\u517b\u4e0e\u6162\u6027\u75c5\u72b6\u51b5\u62a5\u544a(2020\u5e74)]. Acta Nutrimenta Sinica, 42(6), 521. in Chinese.","journal-title":"Acta Nutrimenta Sinica"},{"key":"e_1_3_8_30_1","unstructured":"(NHSA) N. H. S. A. (2024). 2024 work plan for adjusting the national medical insurance Catalog (NMIC) for basic medical insurance work-related injury insurance and maternity insurance\u201d and related application guidelines [\u56fd\u5bb6\u533b\u7597\u4fdd\u969c\u5c40\u5173\u4e8e\u516c\u5e03\u300a2024\u5e74\u56fd\u5bb6\u57fa\u672c\u533b\u7597\u4fdd\u9669\u3001\u5de5\u4f24\u4fdd\u9669\u548c\u751f\u80b2\u4fdd\u9669\u836f\u54c1\u76ee\u5f55\u8c03\u6574\u5de5\u4f5c\u65b9\u6848\u300b\u53ca\u7533\u62a5\u6307\u5357\u7b49\u6587\u4ef6\u7684\u516c\u544a]. (2024-04-00037). Retrieved from https:\/\/www.nhsa.gov.cn\/art\/2024\/6\/28\/art_109_13084.html."},{"key":"e_1_3_8_31_1","doi-asserted-by":"publisher","DOI":"10.1017\/s0266462320000215"},{"key":"e_1_3_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0270-0255(87)90473-8"},{"key":"e_1_3_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2496(77)90033-5"},{"key":"e_1_3_8_34_1","unstructured":"Social Security Network. (2025). No application required for diabetes and special chronic diseases this year! 95% medical insurance reimbursement ratio threshold fee abolished [\u4eca\u5e74!\u7cd6\u5c3f\u75c5\u6162\u7279\u75c5\u65e0\u9700\u7533\u8bf7 \u533b\u4fdd\u62a5\u9500\u6bd4\u4f8b95% \u95e8\u69db\u8d39\u53d6\u6d88]. Retrieved from http:\/\/shebao.southmoney.com\/yiliao\/202503\/787802.html."},{"key":"e_1_3_8_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000027484"},{"key":"e_1_3_8_36_1","doi-asserted-by":"publisher","DOI":"10.12229\/j.issn.1672-5719.2022.18.009"},{"key":"e_1_3_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejor.2004.04.028"},{"issue":"7","key":"e_1_3_8_38_1","first-page":"603","article-title":"2024 Chinese guidelines for the management of hypertension [\u4e2d\u56fd\u9ad8\u8840\u538b\u9632\u6cbb\u6307\u5357(2024\u5e74\u4fee\u8ba2\u7248)]","volume":"32","author":"Writing Group of Chinese Guidelines for the Management of Hypertension, H. L. o. C.,: Hypertension Branch of China International Exchange and Promotive Association for Medical and Health Care, Geriatric Hypertension Branch of Chinese Geriatric Society, Hypertension Branch of China Aging Health Association, Chinese Stroke Association","year":"2024","unstructured":"Writing Group of Chinese Guidelines for the Management of Hypertension, H. L. o. C.,: Hypertension Branch of China International Exchange and Promotive Association for Medical and Health Care, Geriatric Hypertension Branch of Chinese Geriatric Society, Hypertension Branch of China Aging Health Association, Chinese Stroke Association (Wang, J. G. (2024). 2024 Chinese guidelines for the management of hypertension [\u4e2d\u56fd\u9ad8\u8840\u538b\u9632\u6cbb\u6307\u5357(2024\u5e74\u4fee\u8ba2\u7248)]. Chinese Journal of Hypertension, 32(7), 603\u2013700. https:\/\/qikan.cqvip.com\/Qikan\/Article\/Detail?id=7112805540","journal-title":"Chinese Journal of Hypertension"},{"key":"e_1_3_8_39_1","unstructured":"World Health Organization. (2023a). Kenya essential medicines list 2023 (English). G. o. Kenya. https:\/\/www.who.int\/publications\/m\/item\/kenya\u2013essential-medicines-list-2023-(english)."},{"key":"e_1_3_8_40_1","unstructured":"World Health Organization. (2023b). The selection and use of essential medicines 2023. Executive summary of the report of the 24th WHO Expert Committee on selection and use of essential medicines. (WHO\/MHP\/HPS\/EML\/2023.02). https:\/\/www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2023.01."},{"key":"e_1_3_8_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03743-2"},{"issue":"11","key":"e_1_3_8_42_1","first-page":"28","article-title":"A Study on the multidimensional decision framework for health technology assessment from the perspective of adjusting the medical insurance drug catalog [\u533b\u4fdd\u836f\u54c1\u76ee\u5f55\u8c03\u6574\u89c6\u89d2\u4e0b\u7684\u536b\u751f\u6280\u672f\u8bc4\u4f30\u591a\u7ef4\u5ea6\u51b3\u7b56\u6846\u67b6\u7814\u7a76]","volume":"42","author":"Yan Y.","year":"2023","unstructured":"Yan, Y., Mi, T., & Jiangjiang, H. (2023). A Study on the multidimensional decision framework for health technology assessment from the perspective of adjusting the medical insurance drug catalog [\u533b\u4fdd\u836f\u54c1\u76ee\u5f55\u8c03\u6574\u89c6\u89d2\u4e0b\u7684\u536b\u751f\u6280\u672f\u8bc4\u4f30\u591a\u7ef4\u5ea6\u51b3\u7b56\u6846\u67b6\u7814\u7a76]. Chinese Health Economics, 42(11), 28\u201332. https:\/\/kns.cnki.net\/kcms2\/article\/abstract?v=gHWJqxSIlt3joE7ykc7Cz22r6l5b18CcG74QA31AZk-VQcq7iTlH0oxi65izI_wbTk21PdrMZnmsmulrPGMEGquGXVImqiaZXik_dCO9iaQapGyDJI-emqRg-vQ8sxsWhcE9dS6IhRgE5WhgVCuN9a1Wtq6KQu1hympi-N9nkRYp7odbyeC3br9gAUFczPWXFCqgTcXXPZA=&uniplatform=NZKPT&language=CHS (in Chinese)","journal-title":"Chinese Health Economics"},{"key":"e_1_3_8_43_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.653887"},{"issue":"08","key":"e_1_3_8_44_1","first-page":"21","article-title":"Medical insurance drug admission: (colon)A comparison of Mini \u2013 HTA and RHTA [\u533b\u4fdd\u836f\u54c1\u51c6\u5165: (colon)Mini-HTA\u4e0eRHTA\u9002\u7528\u6027\u6bd4\u8f83]","volume":"34","author":"Yunxiang Z. H. O. N. G.","year":"2025","unstructured":"Yunxiang, Z. H. O. N. G., Lin, Y. I. N., Haipeng, T. A. N. G., Aihong, W. A. N. G., Qianwen, Z. H. A. N. G., & Song, J. I. A. N. G. (2025). Medical insurance drug admission: (colon)A comparison of Mini \u2013 HTA and RHTA [\u533b\u4fdd\u836f\u54c1\u51c6\u5165: (colon)Mini-HTA\u4e0eRHTA\u9002\u7528\u6027\u6bd4\u8f83]. \u200bChina Pharmaceuticals, 34(08), 21\u201325. https:\/\/kns.cnki.net\/kcms2\/article\/abstract?v=gHWJqxSIlt0XeRUAUuFNW1Wda2Cz43ZbZ4U4bMx4_qBDOuL0ZsrC333k1hD5vQ4oX2YuGo2Tu2ZXVYq_P4y7ZcJ5Ur1LONN51NMvyc6WPKcN8UmqMzDTiJ3pdbtBBQpSLMXEwXpc6BtFwn01u8KXUiZEYcEm6S4KuEnZkPBf4RFnZaP9DmKHG_dtXXpjABQ2VO0ocZ5nb64=&uniplatform=NZKPT&language=CHS (in chinese)","journal-title":"\u200bChina Pharmaceuticals"},{"issue":"07","key":"e_1_3_8_45_1","first-page":"769","article-title":"Drug selection guideline for medical institutions [\u533b\u7597\u673a\u6784\u836f\u54c1\u9074\u9009\u6307\u5357]","volume":"33","author":"Zhengxiang L.","year":"2022","unstructured":"Zhengxiang, L., Yu, Z., Lingli, Z., & Rong, D. (2022). Drug selection guideline for medical institutions [\u533b\u7597\u673a\u6784\u836f\u54c1\u9074\u9009\u6307\u5357]. China Pharmacy, 33(07), 769\u2013776. https:\/\/link.cnki.net\/urlid\/50.1055.r.20220318.1350.002 (in Chinese)","journal-title":"China Pharmacy"},{"issue":"4","key":"e_1_3_8_46_1","first-page":"447","article-title":"A quick guideline for drug evaluation and selection in Chinese medical institutions (the Second Edition) [\u4e2d\u56fd\u533b\u7597\u673a\u6784\u836f\u54c1\u8bc4\u4ef7\u4e0e\u9074\u9009\u5feb\u901f\u6307\u5357(\u7b2c\u4e8c\u7248)]","volume":"42","author":"Zhigang Z.","year":"2023","unstructured":"Zhigang, Z., zhanjun, D., & Jianping, L. (2023). A quick guideline for drug evaluation and selection in Chinese medical institutions (the Second Edition) [\u4e2d\u56fd\u533b\u7597\u673a\u6784\u836f\u54c1\u8bc4\u4ef7\u4e0e\u9074\u9009\u5feb\u901f\u6307\u5357(\u7b2c\u4e8c\u7248)]. Herald of Medicine, 42(4), 447\u2013456. (in Chinese)","journal-title":"Herald of Medicine"}],"container-title":["Journal of Pharmaceutical Policy and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/20523211.2026.2701914","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/20523211.2026.2701914","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/20523211.2026.2701914","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:03:30Z","timestamp":1790017410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/20523211.2026.2701914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/20523211.2026.2701914"],"URL":"https:\/\/doi.org\/10.1080\/20523211.2026.2701914","relation":{},"ISSN":["2052-3211"],"issn-type":[{"value":"2052-3211","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=jppp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=jppp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-07-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2701914"}}